78129 RH KLM IMM Production instrument for cell therapy

Summary

The procurement concerns a GMP-compatible production instrument for the final processing of cell therapy products (ATMP), including CAR-T cells. The instrument should support a standardized, automated and functionally closed workflow for final processing of cell products. This includes formulation, addition of formulation buffer and cryoprotectant, homogenization, aliquoting, filling and sealing of the final container. The contract scope includes the purchase of one instrument, with an option for an additional instrument with software and consumables, and optional service agreements/maintenance services.